Home LiteratureArticle Details
PMID: 1371582 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.

Molecular pharmacology ·Vol. 41 ·No. 2 ·1992-02-00 ·Pages 223-9

Gao WY, Han FS, Storm C, Egan W, Cheng YC

Abstract

Phosphorothioate oligodeoxycytidine (S-dCn) was used as a model compound to examine the impact of the number of phosphorothioate linkages and their position on the inhibition of human DNA polymerases and RNase H in vitro. S-dCn with a chain length longer than 15 could inhibit human DNA polymerases and RNase H activities, in a linkage number-dependent manner. Longer oligomers were more potent inhibitors than shorter ones. Kinetic studies indicated that S-dC28 was a competitive inhibitor of DNA polymerase alpha and beta with respect to the DNA template, whereas it was a noncompetitive inhibitor of polymerases gamma and delta. S-dC28 was also a competitive inhibitor of RNase H1 and H2 with respect to RNA-DNA duplex. Susceptibility of these enzymes to inhibition by S-dC28 was in the order of delta approximately gamma greater than alpha greater than beta and RNase H1 greater than RNase H2. Structural-activity relationships were explored with a group of S-dC28 analogs that have phosphorothioate internucleotide linkages at various positions. The inhibitory effect depended on the total number of thioate linkages, rather than the position of the linkages within the oligomer or the chain length itself. No sequence specificity was found. In the presence of the complementary RNA, antisense phosphorothioates (S-oligos) exerted a biphasic effect on RNase H activity. At low concentrations S-oligos could enhance the cleavage of the RNA portion of S-oligo-RNA duplex, whereas at high concentrations (in excess of the complementary RNA) S-oligos could inhibit RNase H and protect the complementary RNA from degradation. Together, these results suggest that the non-sequence-specific inhibitory effect of S-oligos should be taken into consideration in designing antisense inhibitors. This inhibitory activity could be avoided by decreasing the number of phosphorothioate linkages at the backbone, and S-oligos of 15-20 residues are preferable in antisense molecule design.

MeSH Terms
Base Sequence Dose-Response Relationship, Drug Humans Kinetics Molecular Sequence Data Nucleic Acid Synthesis Inhibitors Oligodeoxyribonucleotides/pharmacology Oligonucleotides/pharmacology Oligonucleotides, Antisense/pharmacology RNA/metabolism Ribonuclease H/antagonists & inhibitors Structure-Activity Relationship Thionucleotides/pharmacology
Chemicals
Nucleic Acid Synthesis Inhibitors Oligodeoxyribonucleotides Oligonucleotides Oligonucleotides, Antisense Thionucleotides RNA Ribonuclease H
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Gao W Y
Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510.
Han F S
Storm C
Egan W
Cheng Y C
Article Info
Journal
Molecular pharmacology
Abbr.
Mol Pharmacol
ISSN
0026-895X
Published
1992-02-00
Pages
223-9
Language
English
Region
United States
NLM ID
0035623
Subset
IM
Grants
NCI NIH HHS · CA-44358 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]